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Edmond G. Lemire,6 R. Curtis Rogers,7 Aizeddin A. Mhanni,2 Ian G. Phelps,1 Steven J.M. Jones,8
Shing H. Zhan,8 Anthony P. Fejes,8 Hashem Shahin,9 Moien Kanaan,9 Hatice Akay,10
Mustafa Tekin,11,12 FORGE Canada Consortium,13 Barbara Triggs-Raine,2 and Teresa Zelinski2,3,*
Autosomal-recessive inheritance, severe to profound sensorineural hearing loss, and partial agenesis of the corpus callosum are hall-
marks of the clinically well-established Chudley-McCullough syndrome (CMS). Although not always reported in the literature, frontal
polymicrogyria and gray matter heterotopia are uniformly present, whereas cerebellar dysplasia, ventriculomegaly, and arachnoid cysts
are nearly invariant. Despite these striking brain malformations, individuals with CMS generally do not present with significant neuro-
developmental abnormalities, except for hearing loss. Homozygosity mapping and whole-exome sequencing of DNA from affected
individuals in eight families (including the family in the first report of CMS) revealed four molecular variations (two single-base dele-
tions, a nonsense mutation, and a canonical splice-site mutation) in the G protein-signaling modulator 2 gene, GPSM2, that underlie
CMS. Mutations in GPSM2 have been previously identified in people with profound congenital nonsyndromic hearing loss (NSHL).
Subsequent brain imaging of these individuals revealed frontal polymicrogyria, abnormal corpus callosum, and graymatter heterotopia,
consistent with a CMS diagnosis, but no ventriculomegaly. The gene product, GPSM2, is required for orienting the mitotic spindle
during cell division in multiple tissues, suggesting that the sensorineural hearing loss and characteristic brain malformations of CMS
are due to defects in asymmetric cell divisions during development.The autosomal-recessively inherited disorder, Chudley-
McCullough Syndrome (CMS [MIM 604213]), was first
described1 in Canadian siblings of Dutch-German Menno-
nite (sometimes referred to as Old Colony or Chortitza
Mennonite) ancestry, who presented with hydrocephalus
and profound sensorineural hearing loss. Several subse-
quent reports2–8 have expanded the clinical phenotype
to include partial agenesis of the corpus callosum, frontal
polymicrogyria, gray matter heterotopia, cerebellar
dysplasia, and arachnoid cysts. This combination of brain
malformations is highly distinctive and not seen in any
other genetic syndrome.
In an effort to identify mutations that cause CMS, we re-
cruited individuals with CMS from centers in Canada and
the United States. Study subjects were enrolled with
informed consent under protocols approved by the health
research ethics boards of the participating academic insti-
tutions. All affected individuals had severe or profound
sensorineural hearing loss and ventriculomegaly (Table 1).
Brain imaging revealed additional findings characteristic of
the syndrome, including posterior agenesis of the corpus
callosum, frontal polymicrogyria, frontal heterotopia, cere-
bellar dysplasia, and arachnoid cysts (Figure 1, Table 2).
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and low-set, posteriorly rotated ears.1 Only subject 3B
had developmental issues beyond what is typically seen
in individuals with severe hearing loss (Table 1). Perhaps
most surprising given the polymicrogyria and heterotopia
in all individuals, seizures were present in only two
subjects (3B and 7B), and they were well controlled with
medication.
In four Mennonite families, genomic DNA from six
affected individuals and their unaffected relatives was gen-
otyped with the Affymetrix GeneChip Human Mapping
250K NspI SNP array. Loss of heterozygosity on chromo-
some 1p was observed in all six affected individuals, but
not in any member of their extended families. Four of
the six individuals studied were identically homozygous
for a 5.8 Mb region (range: 8.3 Mb to 76.5 Mb). The re-
maining two individuals (a sister and brother) also shared
a homozygous interval on 1p, but their haplotype differed
from the other four affected individuals. Overlap between
the two unique haplotypes was approximately 2.9 Mb
(from rs2863991 to rs402684), a chromosomal segment
within 1p13.3 containing 42 known and putative genes
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Table 1. Clinical Features in Subjects with GPSM2-Related Chudley-McCullough Syndrome
Indiv.a Sex Age
DNA
Change
Protein
Change Ethnicity
Hearing
Loss
Aids/
Implants
Motor
Delay
Comm.
Delayb
Cognitive
Impairment
Other
Features
1A M 1 yr c.1471delG p.G491GfsX6 Mennonite severe cochlear
implant
mild mild no none
2A F 25 yr c.1471delG p.G491GfsX6 Mennonite severe cochlear
implant
no no no none
3A M 12 yr c.1471delG p.G491GfsX6 Mennonite severe none no yes mild none
3B F 15 yr c.1471delG p.G491GfsX6 Mennonite severe none yes yes mild to
moderate ID
h/o seizures,
now off
medications
4A F 4 yr c.1471delG p.G491GfsX6 Mennonite profound cochlear
implant
mild mild mild none
5A F 17 yr c.741delC p.N247NfsX34 Mennonite severe-
profound
cochlear
implant
no no no none
5B M 21 yr c.741delC p.N247NfsX34 Mennonite profound cochlear
implant
no mild,
resolved
no downslanting
palpebral fissures,
rotated ears,
nasal voice
6A F 2 yr c.741delC p.N247NfsX34 European-
American
profound cochlear
implant
mild no no none
7A F 10 yr c.741delC p.N247NfsX34 Dutch profound cochlear
implant
no no mild,
resolved
none
c.1661C>A p.S554X
7B F 4 yr c.741delC p.N247NfsX34 Dutch severe-
profound
cochlear
implant
mild, mildly
increased
tone
mild,
resolving
mild,
resolved
controlled
seizures, breath
holdingc.1661C>A p.S554X
8A F 7 yr c.1062þ1G>T p.R318RfsX8 Mexican-
American
profound cochlear
implant
mild no no none
8B M 6 yr c.1062þ1G>T p.R318RfsX8 Mexican-
American
profound cochlear
implant
mild no no none
Previously Published Subjects with GPSM2Mutations9,10
9A, Walsh9 CG6 M 26 yr c.379C>T p.R127X Palestinian severe-
profound
none no no no none
10A, Yariz10 IV-1 F 16 yr c.1684C>T p.Q562X Turkish severe-
profound
none no no no none
10B, Yariz10 IV-2 M 12 yr c.1684C>T p.Q562X Turkish severe-
profound
none no no no none
11A,c Yariz10 IV-3 M 16 yr c.1684C>T p.Q562X Turkish severe-
profound
none no no no none
Indiv., individual; Comm., communication; M, male; F, female; yr, years of age; ID, intellectual disability; h/o, ‘‘history of.’’
aA and B indicate siblings.
bMore than expected for severe to profound hearing loss.
c11A is a first cousin of 10A and 10B.As part of a cross-Canada initiative known as FORGE
(Finding of Rare Disease Genes), genomic DNA from two
Mennonite individuals (one of each unique haplotype
described above) and four non-Mennonite affected indi-
viduals from other parts of Canada and the United States
were subjected to whole-exome sequencing. Details of
exome-capture-library preparation, sequencing, and bioin-
formatics analysis can be found in Supplemental Data
(available online). In brief, the span of the human genome
covered by at least one qualified aligned read (total
sequence yield) averaged 1.77 Gb per subject (Table S1).
More than 23,000 sequence variants were identified in
each subject with > 12,000 of these being nonsynony-The Americmous variants. Although more than 2,500 identified vari-
ants per subject were not cataloged in dbSNP129 or
dbSNP130, only about 200 per subject were novel; that
is, not listed in the 1000 Genomes Project database or
the noncancer genome database compiled at the Michael
Smith Genome Sciences Centre (Vancouver, BC, Canada).
Of these 200 novel variants, the only gene within the
identified homozygous SNP interval that carried biallelic
mutations in all six sequenced subjects was the G pro-
tein-signaling modulator 2 gene (GPSM2 [MIM 609245]).
The mutations identified with exome sequencing were
verified with Sanger sequencing in all affected subjects
and, when available, in the extended family of eachan Journal of Human Genetics 90, 1088–1093, June 8, 2012 1089
Figure 1. Characteristic Neuroimaging Features of GPSM2-
related Chudley-McCullough Syndrome
(A) illustrates posterior agenesis of the corpus callosum (bracket
indicates remaining corpus callosum) and a quadrigeminal plate
cistern cyst (white plus sign) causingmass effect on the cerebellum
and tectum in individual 8A at 3 years of age.
(B) illustrates severe ventriculomegaly (black asterisks) and
frontal polymicrogyria (white arrows) in individual 8B at 6months
of age.
(C) illustrates large frontal gray matter heterotopia (white arrow-
heads) located superior and medial to the enlarged lateral ventri-
cles (black asterisks) in individual 8A at 3 years of age.
(D) illustrates inferior cerebellar hemisphere dysplasia in indi-
vidual 8B at 6 months of age.
(E) and (F) illustrate a short corpus callosum (bracket indicates
remaining corpus callosum) and a quadrigeminal plate cistern
cyst (black plus sign) causing mass effect on the cerebellum and
tectum as well as cerebellar hemisphere dysplasia in individual
9A (CG6 from Walsh et al.9) at 26 years of age.
1090 The American Journal of Human Genetics 90, 1088–1093, Juneproband. The first mutation, a homozygous single-base
deletion (c.1471delG) predicted to cause a frameshift
(p.Gly491GlyfsX6), was identified in all four Mennonite
subjects (1A, 2A, 3A, and 3B) who displayed the 5.8 Mb
SNP haplotype (Figure 2A) and was also detected in subject
4A, who was not analyzed for SNPs. The second mutation,
also a homozygous single-base deletion (c.741delC) pre-
dicted to cause a frameshift (p.Asn247AsnfsX34), was
identified in the Mennonite sister and brother (5A and
5B) of the second haplotype and in an unrelated subject
(6A) of European ancestry from the southern United States
(Figure 2B). Affected siblings (7A and 7B) of Dutch ancestry
were heterozygous for the c.741delC mutation (paternally
transmitted) and also for a maternally transmitted
c.1661C>A (p.Ser554X) mutation (Figure 2C). The final
two subjects were siblings of Mexican ancestry (8A and
8B) who were found to be homozygous for a mutation in
the donor splice site for exon 9, c.1062þ1G>T (Figure 2D).
This mutation results in a transcript that is missing exon 9
(Figure 2E) and is predicted to generate a truncated protein,
p.Arg318ArgfsX8.
Two of the four mutations were defined in individuals of
Mennonite ancestry and probably represent foundermuta-
tions of European origin. Although the c.1661C>A muta-
tion was not in dbSNP129 or dbSNP130, it is now listed
as rs145191476, having been identified (as heterozygous)
in one of 3,510 European-American subjects who partici-
pated in the National Heart, Lung, and Blood Institute
Grand Opportunity Exome Sequencing Project (NHLBI
GO ESP; see Web Resources). We identified this change
in CMS-affected siblings of Dutch ancestry (7A and 7B),
confirming that this allele is also of European origin.
The origin of the identified splice-site mutation
(c.1062þ1G>T) in the affected siblings of Mexican
ancestry is unknown, and it was absent from 3,510 Euro-
pean-American subjects in the NHLBI GO ESP data set.
Recently, a GPSM2 nonsense mutation, c.875C>T
(p.Arg127X), was reported as the cause of recessively in-
herited nonsyndromic hearing loss (NSHL) (DFNB82) in a
large Palestinian family.9 Subsequently, a second nonsense
mutation, c.1684C>T (p.Gln562X), was identified in
a Turkish family whose members also displayed profound
hearing loss,10 confirming that GPSM2 is one of more
than 50 genes in which mutations are known to cause
recessive deafness.11 Given the identification of GPSM2
mutations in individuals with CMS and in individuals
with profound, apparently nonsyndromic hearing loss,
we investigated whether the latter group might have
asymptomatic brain malformations. Brain imaging was
performed on one affected individual from the Palestinian(G) and (H) illustrate similar findings in individual 10B (IV-2 from
Yariz et al.10) at 12 years of age, although the corpus callosum is
thinned posteriorly and dysplastic anteriorly, rather than short.
(A) and (G) are sagittal T1-weighted images; (B)–(D), (F), and (H)
are axial T2-weighted images, and (E) is a sagittal T2-weighted
image.
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Table 2. Neuroimaging Features in Subjects with GPSM2-Related Chudley-McCullough Syndrome
Individuala Ventriculomegaly CC Heterotopia Frontal PMG Cerebellar Dysplasia Arachnoid Cyst
1A yes posterior agenesis small moderate unable to score
due to mass effect
large bilateral CPA cysts
2A yes, right > left posterior agenesis moderate presentb yes ND
3A shunted HC posterior agenesis small extensive yes no, right ventricle herniation
into midline
3B shunted HC posterior agenesis small moderate yes left CPA
4A yes posterior agenesis extensive extensive no right CPA
5Ac HC, foramen of
Monro fenestration
probable partial
agenesis
ND ND ND ND
5Bc shunted HC probable partial
agenesis
ND ND ND ND
6A shunted HC posterior agenesis small extensive yes large interhemispheric and
small left CPA cysts
7A yes posterior agenesis small moderate yes moderate interhemispheric cyst
7B shunted HC posterior agenesis small moderate yes small pineal cyst
8A yes posterior agenesis large extensive yes large interhemispheric and
small bilateral CPA cysts
8B shunted HC posterior agenesis moderate extensive yes moderate interhemispheric
and small right CPA cysts
Previously Published Subjects with GPSM2Mutations9,10
9A, Walsh9 CG6 no short and thin moderate moderate yes moderate interhemispheric cyst
10A, Yariz10 IV-1 no short and thin small subtle no moderate interhemispheric cyst
10B, Yariz10 IV-2 no short, severely
thin posteriorly
moderate subtle yes small interhemispheric cyst
11A,d Yariz10 IV-3 no short and thin small subtle mild on right moderate interhemispheric cyst
CC, corpus callosum; CPA, cerebellopontine angle; HC, hydrocephalus; ND, no data; PMG, polymicrogyria.
aA and B indicate siblings.
bUnable to determine the extent due to technical limitations of the available images.
cOnly computed tomography scans available.
d11A is a first cousin of 10A and 10B.family and all three affected individuals from the Turkish
family. Despite the fact that study subjects 9A, 10A, 10B,
and 11A did not exhibit any neurological deficits (Table 1),
all four individuals displayed imaging features consistent
with CMS (Table 2 and Figure 1E–1H). In contrast to the
CMS subjects, none of the individuals studied solely
because of hearing loss had ventriculomegaly, and the
corpus callosum abnormalities tended to be less severe.
Genotype-phenotype correlations were not apparent, in
that the individuals (5A, 5B, 6A, and 9A) with GPSM2
mutations predicted to result in the shortest proteins
(p.Asn247AsnfsX34 and p.Arg127X) did not have more
severe brain malformations or clinical features than the
other subjects studied.
The GPSM2 mutations identified in individuals with
CMS highlight the role of GPSM2 in normal brain develop-
ment and in mechanisms that underlie common brain
malformations, such as partial agenesis of the corpus cal-
losum, heterotopia, and polymicrogyria. During early neu-
rogenesis in the mouse cerebral cortex, Gpsm2 is required
for planar orientation of the mitotic spindle in apicalThe Americprogenitor cells (radial glia).12,13 In mice, an engineered
variant (DC) very similar to the human p.Gly491GlyfsX6
variant (Figure 2F) results in abnormally localized apical
progenitors but does not seem to radically affect the
number or organization of cortical neurons, although
phenotypes in mature mouse brain have not been pub-
lished.13,14 It is tempting to speculate that the ectopic
neuronal precursors could result in heterotopic neurons
analogous to the heterotopia observed in individuals
with CMS. GPSM2 is also required for correct spindle orien-
tation in keratinocyte progenitors,15 T cells,16 oocytes,17
and epithelial cells,18 as well as for neurotransmitter local-
ization in mature neurons.19 Given this central role of
GPSM2 (also known as LGN [Leu-Gly-Asn repeat-enriched
protein] and Pins [Partner of Inscuteable, homolog of
Drosophila]) in cell division, it is surprising that truncating
mutations do not cause more widespread defects in indi-
viduals with CMS and in the mouse model.
In conclusion, we provide compelling evidence that
GPSM2 mutations account for CMS in most, if not all,
affected individuals, confirming a role for GPSM2 inan Journal of Human Genetics 90, 1088–1093, June 8, 2012 1091
Figure 2. GPSM2 Sequence Analysis and GPSM2 Schematic
With the use of the primers specified in Table S2, genomic DNA from each subject was PCR-amplified, and the products were isolated
and purified, as described in Supplemental Data. Sanger sequencing was conducted on both the forward and reverse strand; only
the forward strand is shown here. The reference (ref.) sequence (NM_013296.4) is depicted directly below the variant sequence in
each panel.
(A) depicts the c.1471delG mutation identified in five subjects.
(B) depicts the c.741delC homozygous mutation identified in three subjects. Two other study subjects were heterozygous for this
mutation (sequence not shown).
(C) depicts the c.1661C>A heterozygous mutation from one of the two subjects who was also heterozygous for c.741delC.
(D) depicts the homozygous splice-site mutation identified in siblings 8A and 8B.
(E) depicts the effect of the splice-site mutation on the splicing of exon 9. Primers in exons 8 and 9 generated a ~200 base-pair (bp)
product in the unaffected control, but no product in subjects 8A and 8B. Primers in exons 8 and 10 generated a ~300 bp fragment in
the control and a ~200 bp product in subjects 8A and 8B, consistent with the loss of exon 9. Sequencing of this product revealed
that exon 8 is spliced to exon 10 in the affected siblings (data not shown). The horizontal arrows indicate the primer positions; the
vertical red arrow indicates the location of the splice-site mutation. ‘‘lad’’ indicates the ladder lane and ‘‘C’’ indicates the control lanes.
The expected exon composition and size of the various products are indicated to the right of the gel.
(F) depicts the positions of amino-acid variants that account for NSHL and CMS, and includes the mouse-engineered variant DC. Three
of the variants occur within the seven tetratricopeptide repeat domains of GPSM2, and three within the four GoLoco motifs.human brain development. In contrast to others affected
with hydrocephalus, agenesis of the corpus callosum, pol-
ymicrogyria, and heterotopia, individuals with CMS
usually do not have significant cognitive impairment or
seizures. Therefore, GPSM2 sequencing should be per-
formed both in individuals with brain-imaging findings
of CMS and in individuals with sensorineural hearing
loss who have not undergone brain imaging. Identification
ofGPSM2mutations in fetuses and infants with agenesis of
the corpus callosum and heterotopia would greatly alter
prognostic counseling and allow for early detection and1092 The American Journal of Human Genetics 90, 1088–1093, Junetreatment of hearing loss after birth. Although it seems
probable that GPSM2-related defects in asymmetric cell
division underlie the hearing loss and abnormal brain
development in CMS, the mechanistic details remain to
be established through future investigations.Supplemental Data
Supplemental Data include additional methods and two tables
and can be found with this article online at http://www.cell.
com/AJHG/.8, 2012
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